Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3228126
Max Phase: Preclinical
Molecular Formula: C20H41N5O10
Molecular Weight: 511.57
Molecule Type: Small molecule
Associated Items:
ID: ALA3228126
Max Phase: Preclinical
Molecular Formula: C20H41N5O10
Molecular Weight: 511.57
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CNC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](NC)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C20H41N5O10/c1-24-4-8-13(28)14(29)10(23)19(32-8)34-17-6(21)3-7(22)18(16(17)31)35-20-15(30)11(25-2)12(27)9(5-26)33-20/h6-20,24-31H,3-5,21-23H2,1-2H3/t6-,7+,8+,9+,10+,11-,12+,13+,14+,15+,16-,17+,18-,19+,20+/m0/s1
Standard InChI Key: GLGCQNBPJWCQKJ-CPLFCHOMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 511.57 | Molecular Weight (Monoisotopic): 511.2853 | AlogP: -6.80 | #Rotatable Bonds: 8 |
Polar Surface Area: 260.42 | Molecular Species: BASE | HBA: 15 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.39 | CX Basic pKa: 9.59 | CX LogP: -6.30 | CX LogD: -12.46 |
Aromatic Rings: 0 | Heavy Atoms: 35 | QED Weighted: 0.14 | Np Likeness Score: 1.48 |
1. Kumar V, Remers WA.. (1979) Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins., 22 (4): [PMID:107311] [10.1021/jm00190a015] |
Source(1):